These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 32199014)

  • 1. Is serum TWEAK a useful biomarker of neuropsychiatric systemic lupus erythematosus?
    Balajkova V; Olejarova M; Moravcova R; Kozelek P; Posmurova M; Hulejova H; Senolt L
    Physiol Res; 2020 Apr; 69(2):339-346. PubMed ID: 32199014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus.
    Fragoso-Loyo H; Atisha-Fregoso Y; Nuñez-Alvarez CA; Llorente L
    Lupus; 2016 Apr; 25(4):364-9. PubMed ID: 26466614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The blood-brain barrier, TWEAK, and neuropsychiatric involvement in human systemic lupus erythematosus and primary Sjögren's syndrome.
    Lauvsnes MB; Tjensvoll AB; Maroni SS; Kvivik I; Grimstad T; Greve OJ; Harboe E; Gøransson LG; Putterman C; Omdal R
    Lupus; 2018 Nov; 27(13):2101-2111. PubMed ID: 30282561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and urine TNF-like weak inducer of apoptosis, monocyte chemoattractant protein-1 and neutrophil gelatinase-associated lipocalin as biomarkers of disease activity in patients with systemic lupus erythematosus.
    Mirioglu S; Cinar S; Yazici H; Ozluk Y; Kilicaslan I; Gul A; Ocal L; Inanc M; Artim-Esen B
    Lupus; 2020 Apr; 29(4):379-388. PubMed ID: 32041504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum neuron specific enolase - a novel indicator for neuropsychiatric systemic lupus erythematosus?
    Hawro T; Bogucki A; Krupińska-Kun M; Maurer M; Woźniacka A
    Lupus; 2015 Dec; 24(14):1492-7. PubMed ID: 26124236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation of the neutrophin brain-derived neurotrophic factor in neuropsychiatric systemic lupus erythematosus.
    Tamashiro LF; Oliveira RD; Oliveira R; Frota ER; Donadi EA; Del-Ben CM; Teixeira AL; Louzada-Junior P
    Rheumatology (Oxford); 2014 Dec; 53(12):2182-90. PubMed ID: 24942492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric manifestations and associated autoantibodies in systemic lupus erythematosus patients from Western India.
    Pradhan V; Patwardhan M; Rajadhyaksha A; Dhawale N; Ghosh K
    Rheumatol Int; 2015 Mar; 35(3):541-5. PubMed ID: 25119833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of interferon-α as a biomarker in central neuropsychiatric involvement in systemic lupus erythematosus.
    Fragoso-Loyo H; Atisha-Fregoso Y; Núñez-Alvarez CA; Llorente L; Sánchez-Guerrero J
    J Rheumatol; 2012 Mar; 39(3):504-9. PubMed ID: 22247358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences between central nervous system infection and neuropsychiatric systemic lupus erythematosus in patients with systemic lupus erythematosus.
    Fang H; Lan L; Qu Y; Zhang Q; Lv J
    J Int Med Res; 2018 Jan; 46(1):485-491. PubMed ID: 28823196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of human tumor necrosis factor-like weak inducer of apoptosis in patients with systemic lupus erythematosus.
    Wang C; Chen LL; Pan HF; Leng RX; Qin WZ; Ye DQ
    Clin Rheumatol; 2012 Feb; 31(2):335-9. PubMed ID: 21968693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus.
    Ho RC; Thiaghu C; Ong H; Lu Y; Ho CS; Tam WW; Zhang MW
    Autoimmun Rev; 2016 Feb; 15(2):124-38. PubMed ID: 26497108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.
    Fujieda Y; Mader S; Jeganathan V; Arinuma Y; Shimizu Y; Kato M; Oku K; Minami A; Shimizu C; Yasuda S; Atsumi T
    Int J Rheum Dis; 2019 Mar; 22(3):443-448. PubMed ID: 30358102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation Between B-Cell Activating Factor of the Tumor Necrosis Factor Family Level in Serum and Immune Inflammation in Patients with Neuropsychiatric Systemic Lupus Erythematosus and its Clinical Value.
    Pang J; Li Y; Tao R; Li J; Wang F; Xu H
    Immunol Invest; 2024 May; 53(4):559-573. PubMed ID: 38329469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
    Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating microparticles in neuropsychiatric systemic lupus erythematosus.
    Crookston KP; Sibbitt WL; Chandler WL; Qualls CR; Roldan CA
    Int J Rheum Dis; 2013 Feb; 16(1):72-80. PubMed ID: 23441775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological biomarkers in neuropsychiatric systemic lupus erythematosus: a comparative cross-sectional study from a tertiary care center in South India.
    Seth G; Sundaresh A; Mariaselvam CM; Kumar G; Chengappa KG; Adarsh MB; Tamouza R; Negi VS
    Lupus; 2020 Apr; 29(4):413-420. PubMed ID: 32106787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum TWEAK as a biomarker for disease activity of systemic lupus erythematosus.
    Choe JY; Kim SK
    Inflamm Res; 2016 Jun; 65(6):479-88. PubMed ID: 26921306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus.
    Yoshio T; Okamoto H; Kurasawa K; Dei Y; Hirohata S; Minota S
    Lupus; 2016 Aug; 25(9):997-1003. PubMed ID: 26846690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Status of TWEAK DNA methylation and mRNA expression in systemic lupus erythematosus.
    Liao L; Li S; Upreti B; Wang X; Yang Y; Lou X; Li L; Cui R; Liu S; Cheng Y; Xu J
    Lupus; 2023 Feb; 32(2):171-179. PubMed ID: 36418949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
    Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.